AVEO Pharmaceuticals (AVEO) Misses Q3 EPS by 6c

AVEO Pharmaceuticals (NASDAQ: AVEO) reported Q3 EPS of ($0.27), $0.06 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $115 thousand versus the consensus estimate of $3.25 million.

For earnings history and earnings-related data on AVEO Pharmaceuticals (AVEO) click here.

You May Also Be Interested In

• Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
• European stocks rise, helped by positive global sentiment; NatWest gains
• Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth